What we do
An integrated patient-derived platform for preclinical validation
Three layers work together: advanced experimental models, a patient-anchored analysis platform, and the preclinical prediction services built on top of them.
01
Advanced experimental models
- Immortalized cell lines from patient samples
- Roadmap to organoids and PDX
- SOPs and QC for identity, purity and stability
02
Patient-anchored analysis
- Clinical, omics, bioimaging and digital-pathology data
- Convergence into one structured layer
- Powered by AI tools
03
Preclinical prediction
- In vitro efficacy evaluation
- Drug repurposing
- Identification of new therapeutic targets
Data foundation
Every model carries its patient context
Because the biology and the data stay linked, we can study associations between phenotypes, histological patterns and experimental response — the step that turns a model into a prediction.
Anonymized clinical data
Digital pathology & histopathology
Genomics & transcriptomics
Functional response data
Looking for a specific model or assay?
Tell us the pathology and the readout you need — we will tell you what is feasible.